Emerging Infectious Disease Diagnostics Market Poised for Significant Growth by 2031.

InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global Emerging Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report By Application (Laboratory Testing and Point-of-Care Testing), Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, and Other Technologies), Type of Infection (Bacterial, Viral, Fungal, and Other Infections), Disease Type (Respiratory Infections, Sexually Transmitted Infections (STIs), Gastrointestinal Infections, and Other Infections), End Users (Hospitals and Clinics, Diagnostic Laboratories, and Other End Users) Market Outlook And Industry Analysis 2031"

According to the latest research by InsightAce Analytic, the global Emerging Infectious Disease Diagnostics Market size is valued at US$ XX Million in 2022, and it is expected to reach US$ XX Million in 2031, recording a promising CAGR of XX% during the forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2270

Diagnosing infectious diseases includes several methods and techniques used to identify and detect infectious agents in individuals with suspected infection. These diagnostics methods enable accurate and timely diagnosis of disease. Early diagnosis can improve patient outcomes, decrease morbidity & mortality rates, and also prevent the spreading of infectious diseases.

Molecular diagnostics involves techniques like polymerase chain reaction (PCR), sequencing, and nucleic acid amplification tests (NAATs) to detect the genetic material of the infectious agent, which helps in getting specific identification of pathogens, even at low concentrations. Several companies in this market are making efforts in research and developmental activities to improve existing diagnostic methods and invent advanced technologies. Turn-in drives the infectious disease diagnostics market.

The COVID-19 pandemic period has had an intense impact on infectious disease diagnostics worldwide. The surged demand for virus identification and disease control has led to a fast expansion of diagnostic capabilities. The outbreak has also enhanced advancements in point-of-care (POC) testing technologies, allowing rapid and more accessible testing. Therefore, increased focus towards the continuous innovation and development of molecular diagnostics technologies may create lucrative growth opportunities in the emerging infectious disease diagnostics market in the next few years.

Some of the prominent players in the Emerging Infectious Disease Diagnostics Market are:
• Abbott Laboratories
• Becton, Dickinson and Company
• bioMérieux S.A.
• Bio-Rad Laboratories, Inc.
• Co-Diagnostics, Inc.
• DANAHER CORPORATION
• DiaSorin S.p.A.
• F. Hoffmann-La Roche Ltd
• Hologic, Inc.
• QIAGEN N.V.
• QuidelOrtho Corporation
• T2 Biosystems, Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Other

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:
Drivers:
The factors contributing to the growth of the emerging infectious disease diagnostics market include the increasing adoption of Point of Care (PoC) systems, the rising burden of infectious diseases, surging government initiatives & funding to develop diagnostic methods and technological advancements in molecular diagnostics.

The rising burden of infectious diseases:
Infectious diseases have a significant impact on societies worldwide. In addition, disease outbreaks can affect activities such as agriculture, manufacturing, supply chains, tourism, trade, commerce, product delivery, and other services. The prevalence of infectious diseases increases the trend toward preventive medicine, which is estimated to drive the demand for infectious disease diagnostics in the forecast period.

Surging government initiatives & funding to develop diagnostic methods:
Government systems globally are working to allocate and provide funding for the research and early detection of infectious diseases.

Technological Advancements in Molecular Diagnostics:
Scientific R&D activities for developing advanced technologies and methods such as next-generation sequencing (NGS), polymerase chain reaction (PCR), and mass spectrometry are changing the way how molecular diagnostics are performed to detect diseases, contributing to the expansion of infectious disease diagnostics.

Challenges:
Inadequate reimbursements, expensive diagnostics tests, and the lack of established facilities for NGS-based tests to identify infectious diseases are restraining the growth of the infectious disease diagnostics market.

Regional Trends:
North America accounted for the highest revenue share of the emerging infectious disease diagnostics market in 2022. The high prevalence of infectious diseases, technological advancement in diagnostic testing methods, presence of several companies, rising government initiatives to improve healthcare systems, and increasing strategic activities such as collaborations, acquisitions, grants, and others, drive the market.

Key developments in the market:
• In June 2023, T2 Biosystems, Inc. submitted an application to the U.S. Food and Drug Administration (FDA) for breakthrough device designation for the Candida auris Diagnostic test. The company also announced plans to add C. auris detection to its FDA-cleared T2Candida® Panel.
• In April 2023, QIAGEN launched QIAstat-Dx syndromic testing solution in Japan with a respiratory panel for syndromic testing. The SARS-CoV-2 Respiratory Panel can detect more than 20 pathogens from a single patient sample.
• In April 2023, Tecan Trading AG collaborated with DYNEX Technologies to expand the availability of ELISA immunoassays in the U.S.
• In March 2023, QuidelOrtho Corporation received a De Novo Food and Drug Administration (FDA) Authorization for Sofia® 2 SARS Antigen+ FIA. The Sofia 2 SARS Antigen+ FIA is the first rapid antigen test that detects COVID-19 to be awarded FDA market clearance.
• In February 2023, Thermo Fisher Scientific Inc. partnered with Mylab to source RT-PCR test kits for infectious diseases, such as multi-drug resistant tuberculosis (MTB MDR), Hepatitis C virus (HCV), Hepatitis B virus (HBV), Human Immunodeficiency Virus (HIV), genetic analysis (HLA B27), and others.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2270

Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Application
• Laboratory Testing
• Point-of-Care Testing
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Technology
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Next-Generation Sequencing (NGS)
• Immunodiagnostics
• Other Technologies
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Infection
• Bacterial
• Viral
• Fungal
• Other Infections
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Disease Type
• Respiratory Infections
• Sexually Transmitted Infections (STIs)
• Gastrointestinal Infections
• Other Infections
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on End-Users
• Hospitals and Clinics
• Diagnostic Laboratories
• Other End Users
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Emerging Infectious Disease Diagnostics Market Revenue (US$ Million) by Country, 2023 to 2031
• U.S.
• Canada
Europe Emerging Infectious Disease Diagnostics Market Revenue (US$ Million) by Country, 2023 to 2031
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Emerging Infectious Disease Diagnostics Market Revenue (US$ Million) by Country, 2023 to 2031
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Emerging Infectious Disease Diagnostics Market Revenue (US$ Million) by Country, 2023 to 2031
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Emerging Infectious Disease Diagnostics Market Revenue (US$ Million) by Country, 2023 to 2031
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2270

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.